HLS Therapeutics (TSX:HLS) Days Payable : 529.52 (As of Sep. 2024)

View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Days Payable?

HLS Therapeutics's average Accounts Payable for the three months ended in Sep. 2024 was C$17.57 Mil. HLS Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was C$3.03 Mil. Hence, HLS Therapeutics's Days Payable for the three months ended in Sep. 2024 was 529.52.

The historical rank and industry rank for HLS Therapeutics's Days Payable or its related term are showing as below:

TSX:HLS' s Days Payable Range Over the Past 10 Years
Min: 34.82 Med: 746.24 Max: 2467.77
Current: 553.13

During the past 13 years, HLS Therapeutics's highest Days Payable was 2467.77. The lowest was 34.82. And the median was 746.24.

TSX:HLS's Days Payable is ranked better than
94.65% of 953 companies
in the Drug Manufacturers industry
Industry Median: 85.16 vs TSX:HLS: 553.13

HLS Therapeutics's Days Payable declined from Sep. 2023 (651.30) to Sep. 2024 (529.52). It may suggest that HLS Therapeutics accelerated paying its suppliers.

HLS Therapeutics Days Payable Historical Data

The historical data trend for HLS Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Days Payable Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

2,467.77

1,159.31

850.05

746.24

618.66

HLS Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															651.30	508.67	697.32	500.92	529.52

Competitive Comparison of HLS Therapeutics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLS Therapeutics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's Days Payable falls into.

HLS Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

HLS Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (15.746	+	18.926)	/	2 )	/	10.228	*	365
=	17.336					/	10.228	*	365
=	618.66

HLS Therapeutics's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (16.88	+	18.263)	/	2 )	/	3.028	*	365 / 4
=	17.5715					/	3.028	*	365 / 4
=	529.52

HLS Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HLTRF:USA

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.

Executives

Norma Beauchamp	Director
Craig Millian	Director, Senior Officer
Brian Thomas Walsh	Senior Officer
Polar Asset Management Partners Inc.	10% Security Holder
John Gordon Hanna	Director, Senior Officer
Athyrium Opportunities Ii Co-invest 1 Lp	10% Security Holder
Jr. John Lee Welborn	Director
Tim Hendrickson	Senior Officer
William M. Wells	Director, Senior Officer
Gilbert Godin	Director, Senior Officer
Gregory David Gubitz	Director
Orbimed Advisors Llc	10% Security Holder
Jason Gross	Senior Officer
Ryan Christopher Lennox	Senior Officer

HLS Therapeutics Headlines

No Headlines